Agios Pharmaceuticals
AGIO
#5155
Rank
S$2.03 B
Marketcap
S$34.91
Share price
-0.62%
Change (1 day)
-25.82%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -S$0.63 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are S$44.79 Million. In 2024 the company made an earning of -S$0.55 Billion a decrease over its 2023 earnings that were of -S$0.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.63 Billion15.48%
2024 -S$0.55 Billion8.75%
2023 -S$0.5 Billion0.63%
2022 -S$0.5 Billion2.81%
2021 -S$0.49 Billion10.58%
2020 -S$0.44 Billion-18.41%
2019 -S$0.54 Billion15.72%
2018 -S$0.47 Billion12.99%
2017 -S$0.41 Billion59.61%
2016 -S$0.26 Billion69.32%
2015 -S$0.16 Billion119.28%
2014 -S$68.87 Million39.22%
2013 -S$49.47 Million69.1%
2012 -S$29.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.07 B-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.62 B-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.85 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-S$0.18 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$1.11 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.86 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA